A Predictive Model for Initial Platinum‐Based Chemotherapy Efficacy in Patients with Postoperative Epithelial Ovarian Cancer Using Tissue‐Derived Small Extracellular Vesicles
Journal of Extracellular Vesicles · 2024
DOI: 10.1002/jev2.12486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2024. Verfasst von Shizhen Shen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women's Hospital, Zhejiang University School …. Hauptthemen laut MEDLINE: Extracellular Vesicles, Carcinoma, Ovarian Epithelial, Ovarian Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Epithelial ovarian cancer (EOC) is an often‐fatal malignancy marked by the development of resistance to platinum‐based chemotherapy. Thus, accurate prediction of platinum drug efficacy is crucial for strategically selecting postoperative interventions to mitigate the risks associated with suboptimal therapeutic outcomes and adverse effects. Tissue‐derived extracellular vesicles (tsEVs), in contrast to their plasma counterparts, have emerged as a powerful tool for examining distinctive attributes of EOC tissues. In this study, 4D data‐independent acquisition (DIA) proteomic sequencing was performed on tsEVs obtained from 58 platinum‐sensitive and 30 platinum‐resistant patients with EOC. The analysis revealed a notable enrichment of differentially expressed proteins that were predominantly associated with immune‐related pathways. Moreover, pivotal immune‐related proteins (IRPs) were identified by LASSO regression. These factors, combined with clinical parameters selected through univariate logistic regression, were used for the construction of a model employing multivariate logistic regression. This model integrated three tsEV IRPs, CCR1, IGHV_35 and CD72, with one clinical parameter, the presence of postoperative residual lesions. Thus, this model could predict the efficacy of initial platinum‐based chemotherapy in patients with EOC post‐surgery, providing prognostic insights even before the initiation of chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Provincial Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Department of Gynecologic Oncology, School of Medicine, Women's Hospital, Zhejiang University, Hangzhou, Zhejiang, China.
ORCID-Profile: Xiaodong Cheng
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Shen, S., Wang, C., Gu, J., Song, F., Wu, X., Qian, F., Chen, X., Wang, L., Peng, Q., Xing, Z., Gu, L., Wang, F., & Cheng, X. (2024). A Predictive Model for Initial Platinum‐Based Chemotherapy Efficacy in Patients with Postoperative Epithelial Ovarian Cancer Using Tissue‐Derived Small Extracellular Vesicles. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.12486
Vancouver
Shen S, Wang C, Gu J, Song F, Wu X, Qian F, et al. A Predictive Model for Initial Platinum‐Based Chemotherapy Efficacy in Patients with Postoperative Epithelial Ovarian Cancer Using Tissue‐Derived Small Extracellular Vesicles. Journal of Extracellular Vesicles. 2024. doi:10.1002/jev2.12486
BibTeX
@article{Shen2024,
author = {Shen, Shizhen and Wang, Conghui and Gu, Jiaxin and Song, Feifei and Wu, Xiaodong and Qian, Fangfang and Chen, Xiaojing and Wang, Lingfang and Peng, Qiaohua and Xing, Ziyu and Gu, Lingkai and Wang, Fenfen and Cheng, Xiaodong},
title = {A Predictive Model for Initial Platinum‐Based Chemotherapy Efficacy in Patients with Postoperative Epithelial Ovarian Cancer Using Tissue‐Derived Small Extracellular Vesicles},
journal = {Journal of Extracellular Vesicles},
year = {2024},
doi = {10.1002/jev2.12486}
}
EUVIMED